← Back to Search

Behavioural Intervention

Asthma Link for Childhood Asthma

N/A
Recruiting
Led By Michelle Trivedi, MD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Must not have
Child: Unable or unwilling to provide informed assent, Developmental delay that would prevent study participation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months, 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to find out if a program called Asthma Link, supervised by schools, is better at improving asthma symptoms in children aged 5-14 with poorly controlled asthma compared to just using an

Who is the study for?
This trial is for children aged 5-14 with poorly controlled asthma. It's designed to see if a school program called Asthma Link can help manage their symptoms better than an educational workbook.
What is being tested?
The study is testing the effectiveness of 'Asthma Link', which involves supervised asthma therapy at school, against just using an educational workbook on asthma care. Children will be randomly placed in one of these two groups.
What are the potential side effects?
Since specific side effects are not listed for this intervention, they may vary depending on individual reactions to the Asthma Link program or any medications used within it.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My child cannot give informed assent due to developmental delays.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Improving Asthma Symptoms
Secondary study objectives
Improving Healthcare Utilization
Improving Medication Adherence
Improving Quality of Life
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Asthma LinkExperimental Treatment1 Intervention
Practices in the Asthma Link condition will receive brief training on how to identify, refer and arrange for children with poorly controlled asthma to receive school-supervised therapy with the child's school health staff. Participants will receive an educational asthma workbook.
Group II: Enhanced Usual CareActive Control1 Intervention
Practices in the Enhanced Usual Care condition will receive brief training on how to identify and refer the same group of children with poorly controlled asthma and these children will receive an educational asthma workbook.

Find a Location

Who is running the clinical trial?

University of Massachusetts, WorcesterLead Sponsor
361 Previous Clinical Trials
992,592 Total Patients Enrolled
1 Trials studying Childhood Asthma
66 Patients Enrolled for Childhood Asthma
National Institutes of Health (NIH)NIH
2,806 Previous Clinical Trials
8,150,240 Total Patients Enrolled
1 Trials studying Childhood Asthma
627 Patients Enrolled for Childhood Asthma
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,919 Previous Clinical Trials
47,759,448 Total Patients Enrolled
6 Trials studying Childhood Asthma
2,086 Patients Enrolled for Childhood Asthma
~233 spots leftby Jan 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top